Dr. Miki Watanabe, MD

Dr. Watanabe practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Watanabe's NPI, 1366634966, was assigned on August 16, 2007. Dr. Watanabe graduated from Other in 1999. Dr. Watanabe's California license number on file is A102318.

Dr. Watanabe's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Watanabe's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Watanabe to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Watanabe practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Watanabe's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Watanabe is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Watanabe's licenses on file in 5 states: California, Oregon, Colorado, Washington and Pennsylvania.

Dmand AI lists acute respiratory failure, anemia, bile duct problems, cardiac arrhythmia, chronic diabetes, circulation problems, circulatory problems in extremities and congestive heart failure among the conditions Dr. Watanabe treats.

CMS data shows 423 Medicare services from Dr. Watanabe across 6 procedure codes in 2024, for 161 Medicare patients. Medicare paid $41,880 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 161 Medicare patients who saw Dr. Watanabe in 2024. The largest group is 65 to 74, with 54 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 66% are also on Medicaid. Their average risk score is 3.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Watanabe's median patient age at 61, with 43% women.

In 2024, Dr. Watanabe wrote 83 Medicare Part D claims for 36 patients. 86% of them were for generic drugs. CMS names the drug for 37 of them, across 3 drugs with 11 or more claims each, at $1,231 in total drug cost. In 2022, CMS named 68 claims across 4 drugs.

Dr. Watanabe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Watanabe as offering telehealth.

Dmand AI links 17 papers to Dr. Watanabe, published from 2011 to 2020. 2018 was the busiest year, with 6. The most frequent topics are Metabolome, Metabolomics and Cell Line, Tumor. Dr. Watanabe has published most often in Metabolomics. Dr. Watanabe's most frequent co-authors are Adam Lane, MD, Christopher Eugene Dandoy, MD and Stella M. Davies, MD.

CMS Open Payments shows 2 general payments to Dr. Watanabe from 2 drug and device companies from 2017 to 2018. Education make up the largest share, 76% of the total. Astellas Pharma US Inc paid the most, $70.

Dr. Watanabe graduated from Other in 1999.

Dr. Watanabe is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.